|
|
Office Locations:
|
699 Boylston Street, 14th Floor
Boston, MA 02116
Phone: 617-351-2800
Fax: 617-351-2801
| | |
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
|
Founded in 1989, Riverside Partners invests in leading healthcare and technology companies based in North America, with a particular focus on companies that are founder- and family-owned. Riverside targets proven, profitable companies with revenues between $20 million and $200 million. The companies in which Riverside has invested typically generate sales between $10 million and $100 million, and EBITDA between $3 million and $15 million. The firm focuses on companies with headquarters in North America. The firm is currently investing Riverside Fund V, L.P., a $561 million equity fund, with committed capital from leading institutional investors, including endowments and foundations, family offices, pension funds, and fund of funds.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
